Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ophthalmic Plast Reconstr Surg ; 34(1): 49-54, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-28072612

RESUMEN

PURPOSE: To report surgical site infection (SSI) rates of eviscerations and enucleations with implants performed without perioperative intravenous (IV) antibiotics or postoperative oral antibiotics, and to give SSI prevention recommendations. METHODS: A single-center retrospective chart review was performed after obtaining institutional review board approval. Charts were found by Current Procedural Terminology codes. Demographics, surgical indication, procedure, implant, antibiotic use, and postoperative course were recorded. SSIs occurring within 30 days after surgery were reviewed and postoperative infection rates were determined. RESULTS: Four hundred eighty-one cases from January 1999 to December 2015 were analyzed. There were 102 eviscerations with implants, 314 enucleations with implants, 23 enucleations without implants, 23 implant exchanges, 15 implants placed secondarily after enucleation, and 4 implant removals. Seventy cases (14.6%) were given perioperative IV antibiotics, and in this group one periorbital infection occurred unrelated to orbital surgery (1.4%). Of the 411 cases (85.4%) not given perioperative IV antibiotics, 1 of 87 eviscerations with implants developed an SSI (1.1%), 2 of 273 enucleations with implants developed SSIs (0.7%), and none of the 13 enucleations without implants developed SSIs. CONCLUSIONS: To our knowledge, this is the first published case series reporting SSI rates of enucleations and eviscerations with implants performed without perioperative IV antibiotics or postoperative oral antibiotics. With infection rates comparing favorably to other case series where antibiotics were given, the routine use of perioperative IV antibiotics and postoperative oral antibiotics for enucleations and eviscerations may not be indicated.


Asunto(s)
Antibacterianos/uso terapéutico , Profilaxis Antibiótica/métodos , Oftalmopatías/cirugía , Enucleación del Ojo/métodos , Evisceración del Ojo/métodos , Infección de la Herida Quirúrgica/prevención & control , Adulto , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
2.
Ophthalmic Plast Reconstr Surg ; 30(2): 175-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24614548

RESUMEN

PURPOSE: To evaluate the use of hyaluronic acid gel in the management of lagophthalmos in sunken superior sulcus syndrome. INTRODUCTION: Lagophthalmos associated with orbital fat atrophy and deep superior sulcus is a known entity described previously. Orbital fat atrophy results in deep superior sulcus where skin, orbicularis muscle, and orbital septum retract posteriorly in the deep superior sulcus, leading to lagophthalmos from suboptimal orbicularis function and effective skin shortening. The authors define this condition as sunken superior sulcus syndrome (SSSS) when the deep superior sulcus leads to exposure keratopathy. Thus, the syndrome consists of deep superior sulcus, lagophthalmos, and exposure keratopathy. Although the use of hyaluronic acid gel has been proposed as a management option for paralytic lagophthalmos, its application in the treatment of lagophthalmos in SSSS has not been reported. METHODS: In this study, 5 patients (10 eyelids) with SSSS were injected with hyaluronic acid gel in the superior sulcus of the upper eyelid. Injected amount was titrated until the desired point was reached: complete or nearly complete eyelid closure. RESULTS: After an average follow up of 9.5 months, lagoph thalmos improved by 2 mm or 69% (p = 0.02) on the right side and by 1 mm or 71% (p = 0.01) on the left side. Most patients also reported significantly improved ocular comfort and appearance of the superior sulcus. The only complications noted were bruising and temporary uneven contour of the upper eyelid sulcus. CONCLUSIONS: Management of lagophthalmos in SSSS with hyaluronic acid gel is an effective and safe alternative to surgery.


Asunto(s)
Enoftalmia/tratamiento farmacológico , Enfermedades de los Párpados/tratamiento farmacológico , Párpados/efectos de los fármacos , Ácido Hialurónico/administración & dosificación , Viscosuplementos/administración & dosificación , Tejido Adiposo/patología , Anciano , Anciano de 80 o más Años , Atrofia , Enoftalmia/etiología , Enoftalmia/fisiopatología , Enfermedades de los Párpados/etiología , Enfermedades de los Párpados/fisiopatología , Párpados/fisiopatología , Femenino , Geles , Humanos , Ácido Hialurónico/uso terapéutico , Inyecciones Intraoculares , Persona de Mediana Edad , Músculos Oculomotores/fisiopatología , Órbita/patología , Viscosuplementos/uso terapéutico
3.
Curr Opin Ophthalmol ; 24(5): 488-93, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23925062

RESUMEN

PURPOSE OF REVIEW: Botulinum toxin (BTX) injections are the main medical treatment of facial dystonias, but injections are ineffective in some patients. This review discusses the indications for myectomy and surgical technique for treating benign essential blepharospasm (BEB) and apraxia of eyelid opening (ALO). RECENT FINDINGS: There are four reasons to consider myectomy for patients with BEB. The first is ALO associated with BEB. The second is patients with blepharospasm-associated deformities. The third is patients who are truly unresponsive to BTX. The fourth is patients who cannot afford or who refuse BTX injections. SUMMARY: Myectomy remains essential for treating blepharospasm patients and the most common indication is those with associated ALO.


Asunto(s)
Blefaroespasmo/cirugía , Músculos Oculomotores/cirugía , Procedimientos Quirúrgicos Oftalmológicos , Apraxias/cirugía , Humanos
4.
Facial Plast Surg ; 29(4): 273-80, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23884848

RESUMEN

Lower eyelid blepharoplasty is one of the most common procedures in aesthetic plastic surgery. Although patients desiring lower eyelid blepharoplasty typically describe their problem as "bags in the lower eyelids," there are many anatomical imperfections that should be assessed. With aging, the youthful single convexity of the lower lid separates into a double convexity with a valley at the intersection of the lower lid and midface. Midface descent further drags this intersection inferiorly, leading to a vertically lengthened lower eyelid. This article discusses how to clinically evaluate lower lid deformities, how to formulate a surgical plan, the preoperative assessment, and surgical markings. The rationale and anesthetic technique for outpatient versus in-office surgery is reviewed, and a detailed step-by-step approach with accompanying figures for lower lid blepharoplasty via a transconjunctival or transcutaneous incision is given. An approach to vertically supporting the lower eyelid is presented.


Asunto(s)
Blefaroplastia/métodos , Rejuvenecimiento , Ritidoplastia/métodos , Tejido Adiposo/cirugía , Procedimientos Quirúrgicos Ambulatorios/métodos , Quimioexfoliación/métodos , Conjuntiva/cirugía , Procedimientos Quirúrgicos Dermatologicos/métodos , Disección/instrumentación , Disección/métodos , Estética , Enfermedades de los Párpados/cirugía , Párpados/patología , Párpados/cirugía , Músculos Faciales/cirugía , Humanos , Órbita/cirugía , Planificación de Atención al Paciente , Examen Físico , Envejecimiento de la Piel/patología
5.
Cornea ; 29(2): 152-8, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20023588

RESUMEN

PURPOSE: The purposes of this study were to describe 2 contact lens-associated Beauveria keratitis cases and to compare the isolates of 3 contact lens-associated Beauveria keratitis cases with Beauveria-based biopesticides using random amplification of polymorphic DNA (RAPD). METHODS: A 55-year-old diabetic woman from New Mexico and a 31-year-old healthy woman from southern Wisconsin developed soft contact lens-related corneal ulcers unresponsive to topical moxifloxacin and prednisolone acetate drops. Their corneal cultures grew B. bassiana. These isolates, an isolate from a third soft contact lens-related Beauveria keratitis case, and Beauveria-based biopesticides sold in the United States were analyzed using morphological features, DNA sequencing, and RAPD. A PubMed, Cochrane Library, OVID, UpToDate, and Google search using the term "Beauveria" found only 9 reported Beauveria keratitis infections. RESULTS: Patient 1 responded to topical natamycin, ketoconazole, and 200 mg oral ketoconazole twice daily before developing a secondary bacterial infection requiring penetrating keratoplasty. After subsequent cataract surgery, the best-corrected visual acuity was 20/20. Patient 2 was treated with topical natamycin, topical amphotericin, and 200 mg oral voriconazole twice daily for 1 month with residual scarring and a best-corrected visual acuity of 20/25. RAPD showed that all isolates were unrelated. CONCLUSIONS: Although earlier reported Beauveria keratitis cases occurred after corneal injury in patients who did not wear contact lenses, 3 recent patients wore soft contact lenses and denied trauma, mirroring a changing trend in microbial keratitis. RAPD analysis showed that the Beauveria isolates were unrelated to one another and to Beauveria-based biopesticides. In Patient 2, oral voriconazole worked well.


Asunto(s)
Beauveria/aislamiento & purificación , Lentes de Contacto Hidrofílicos/microbiología , Úlcera de la Córnea/microbiología , Infecciones Fúngicas del Ojo/microbiología , Micosis/microbiología , Adulto , Antifúngicos/uso terapéutico , Beauveria/genética , Úlcera de la Córnea/diagnóstico , Úlcera de la Córnea/tratamiento farmacológico , ADN de Hongos/análisis , Quimioterapia Combinada , Infecciones Fúngicas del Ojo/diagnóstico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Femenino , Humanos , Persona de Mediana Edad , Micosis/diagnóstico , Micosis/tratamiento farmacológico , Control de Plagas , Pirimidinas/uso terapéutico , Técnica del ADN Polimorfo Amplificado Aleatorio , Triazoles/uso terapéutico , Voriconazol
6.
Ophthalmology ; 114(11): 2090-4, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17686521

RESUMEN

OBJECTIVE: To describe the clinical and histopathologic findings of a unique case of isolated optic nerve Blastomyces dermatitidis infection and to summarize the ophthalmic blastomycosis literature. DESIGN: Case report and systematic literature review. METHODS: A 70-year-old healthy man experienced impaired vision in his left eye. Magnetic resonance imaging (MRI) showed an enhancing process of the left optic nerve sheath. Although vision initially improved with oral dexamethasone, visual acuity subsequently decreased from 20/25 to no light perception over 8 weeks. An optic nerve biopsy revealed blastomycosis. Because ophthalmic blastomycosis infections are unusual, the Cochrane Library, PubMed, OVID, and UpToDate databases were searched using the term blastomycosis with the limits English and humans. Articles that predated the databases were gathered from current references. MAIN OUTCOME MEASURES: Visual acuity of the left eye and MRI of the orbits and brain. RESULTS: Histopathologic examination of the nerve specimen showed B. dermatitidis infection. Needle biopsy and culture results of a suspicious lung scar were positive for Blastomyces. The patient was treated with intravenous amphotericin B followed by oral itraconazole for 6 months. The left eye remained blind 23 months after the biopsy. Approximately 40 articles describing ophthalmic infection were found in the literature search. CONCLUSIONS: Ophthalmic blastomycosis infections can cause rapid, complete vision loss. Prompt treatment is required, but infections are uncommon and usually are misdiagnosed, often because of lack of biopsy results. Tissue must be biopsied, cultured, or both for a definitive diagnosis. Because virtually all blastomycosis cases begin in the lungs, a chest radiograph or computed tomographic scan should be obtained. Any questionable lung lesion should be biopsied to corroborate possible ophthalmic disease.


Asunto(s)
Blastomyces/aislamiento & purificación , Blastomicosis/microbiología , Infecciones Fúngicas del Ojo/microbiología , Enfermedades del Nervio Óptico/microbiología , Administración Oral , Anciano , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Biopsia , Blastomicosis/diagnóstico , Blastomicosis/tratamiento farmacológico , Quimioterapia Combinada , Infecciones Fúngicas del Ojo/diagnóstico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Humanos , Infusiones Intravenosas , Itraconazol/uso terapéutico , Imagen por Resonancia Magnética , Masculino , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/tratamiento farmacológico , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/tratamiento farmacológico , Trastornos de la Visión/microbiología , Agudeza Visual , Campos Visuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA